Efficacy of the mHealth-Based Exercise Intervention re.flex for Patients With Knee Osteoarthritis: Pilot Randomized Controlled Trial
JMIR mHealth and uHealth · 09.09.2024 · 12 · e54356
DOI: 10.2196/54356 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift JMIR mHealth and uHealth, online erschienen am 09.09.2024. Verfasst von Valerie Dieter und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Sports Medicine, Medical Clinic, University Hospital Tübingen, Tübingen, Germany. Hauptthemen laut MEDLINE: Osteoarthritis, Knee, Exercise Therapy, Telemedicine. Die Arbeit wurde bisher 33-mal zitiert (Crossref) und nennt 71 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Background
Exercise therapy is recommended by international guidelines as a core treatment for patients with knee osteoarthritis. However, there is a significant gap between recommendations and practice in health care. Digital exercise apps are promising to help solve this undersupply.
Objective
This study aims to evaluate the efficacy of a 12-week fully automated app-based exercise intervention with and without a supporting knee brace on health-related outcomes, performance measures, and adherence in patients with knee osteoarthritis.
Methods
This closed user group trial included participants with moderate to severe unicondylar painful knee osteoarthritis. Randomization was 1:1:2 into an intervention group (IG) with 2 subgroups (app-based training [IG A] and app-based training and a supportive knee brace [IG AB]) and a control group (CG). The intervention included a 12-week home exercise program with 3 sessions per week. Instructions for the exercises were given via the app and monitored using 2 accelerometers placed below and above the affected knee joint. Participants in the CG did not receive any study intervention but were allowed to make use of usual care. Osteoarthritis-specific pain (Knee Injury and Osteoarthritis Outcome Score) was defined as the primary outcome, and secondary outcomes included all other Knee Injury and Osteoarthritis Outcome Score subscales, general health-related quality of life (Veterans RAND 12-item Health Survey), psychological measures (eg, exercise self-efficacy), performance measures (strength and postural control), and the monitoring of adherence and safety. Outcomes were assessed at baseline and after 12 weeks. Intervention effects were calculated using baseline-adjusted analysis of covariance for the joint comparison of IG A and IG AB versus the CG using a per-protocol approach. Subgroup analyses were conducted for each IG separately.
Results
A total of 61 participants were included (IG: n=30, 49%; CG: n=31, 51%; male: n=31, 51%; female: n=30, 49%; mean age 62.9, SD 8.5 years; mean BMI 27.7, SD 4.5 kg/m2). Analysis revealed statistically significant effects in favor of the IG for pain reduction (P
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Sports Medicine, Medical Clinic, University Hospital Tübingen, Tübingen, Germany.
- Interfaculty Research Institute for Sports and Physical Activity, Tübingen, Germany.
ORCID-Profile: Valerie Dieter, Pia Janssen, Inga Krauss
Zitieren
APA
Dieter, V., Janssen, P., & Krauss, I. (2024). Efficacy of the mHealth-Based Exercise Intervention re.flex for Patients With Knee Osteoarthritis: Pilot Randomized Controlled Trial. JMIR mHealth and uHealth, 12, e54356. https://doi.org/10.2196/54356
Vancouver
Dieter V, Janssen P, Krauss I. Efficacy of the mHealth-Based Exercise Intervention re.flex for Patients With Knee Osteoarthritis: Pilot Randomized Controlled Trial. JMIR mHealth and uHealth. 2024;12:e54356. doi:10.2196/54356
BibTeX
@article{Dieter2024,
author = {Dieter, Valerie and Janssen, Pia and Krauss, Inga},
title = {Efficacy of the mHealth-Based Exercise Intervention re.flex for Patients With Knee Osteoarthritis: Pilot Randomized Controlled Trial},
journal = {JMIR mHealth and uHealth},
year = {2024},
volume = {12},
pages = {e54356},
doi = {10.2196/54356}
}
EUVIMED